6 completed. 6 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 6 |
Follow TAK-279: new trials by email Literature Review of TAK-279 trials Research Report on TAK-279
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of TAK-279 in Healthy Chinese Adults TAK-279, Placebo - Healthy Volunteers | Phase 1 | Completed | Takeda | 24 | 2024-06-24 | 2024-08-07 |
| A Study of TAK-279 in Healthy Adults on the Effect on ECG Measurements TAK-279, TAK-279 Placebo, Moxifloxacin - Healthy Volunteers | Phase 1 | Completed | Takeda | 120 | 2024-04-29 | 2024-07-11 |
| A Study of the Interaction of Other Drugs With TAK-279 in Healthy Adults Midazolam, Repaglinide, TAK-279 - Healthy Volunteers | Phase 1 | Completed | Takeda | 20 | 2024-03-29 | 2024-05-23 |
| A Study of TAK-279 in Adults With or Without Kidney Problems TAK-279 - Renal Impairment, Healthy Volunteers | Phase 1 | Completed | Takeda | 24 | 2023-09-27 | 2024-06-27 |
| A Study of TAK-279 in Adults With or Without Liver Damage TAK-279 - Hepatic Impairment, Healthy Volunteers | Phase 1 | Completed | Takeda | 27 | 2023-09-22 | 2024-08-29 |
| A Study of the Interaction of TAK-279 With Substances That Have an Impact on Metabolism in Healthy Adults TAK-279, Erythromycin, Phenytoin - Healthy Volunteers | Phase 1 | Completed | Takeda | 172 | 2023-08-11 | 2024-02-06 |
Takeda (6)
United States (5) · China (1)